China Silent Heart Attack Market Size, Industry Trends, Share and Forecast 2020-2026


Posted August 12, 2020 by mansi3210

China Silent Heart Attack Market Size, Share & Trends Analysis Report by Diagnosis , by Treatment, and by End-User and Forecast, 2020-2026

 
China silent heart attack market is estimated to grow considerably at a CAGR of around 7.8% during the forecast period. Increasing heart attacks in China is projected to offer growth to the silent heart attack market in China during the forecast period. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) causes one-third of the total fatalities each year in China. The medical device market is one of the fastest-growing markets in China with double-digit growth for over a decade. In 2018, the medical device market in the country was around $78.8 billion with an increment of 22% YoY. Hospitals are one of the major contributors to the market owing to a 70% market share. As of November 2018, the country has around 32,000 hospitals, out of which more than 12,000 were public hospitals. As per the Institute for Health Metrics and Evaluation (IHME), the incidence of CVD is increasing continuously in the country. Therefore, the presence of such a large number of hospitals with rising CVD patients is offering growth opportunities to the market players to expand their presence in China.

Request a Free Sample of our China Silent Heart Attack Market: https://www.omrglobal.com/request-sample/china-silent-heart-attack-market

China silent heart attack market is segmented into diagnosis, treatment, and end-user. Based on the diagnosis, the market is segmented into an electrocardiography (ECG), chest x-ray, computed tomography (CT Scan), echocardiography, and others (blood test). Based on treatment, the market is segmented into medication and surgery. Based on end-user, the market is segmented into hospitals & clinics and ambulatory surgical centers (ASCs). Surgery is one of the most commonly required treatments that increase blood flow. Therefore, angioplasty and bypass surgery are significantly used for the management of blocked arteries and improve blood flow to the heart.

A full Report of China Silent Heart Attack Market is Available at: https://www.omrglobal.com/industry-reports/china-silent-heart-attack-market

China Silent Heart Attack Market Segmentation

By Diagnosis

• Electrocardiography (ECG)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)

By Treatment

• Medication
• 5.2.2. Surgery
• Angioplasty
• Bypass Surgery
• Heart Transplant

By End-User

• Hospital & Clinics
• Ambulatory Surgical Centers

Company Profiles

• Astellas Pharma, Inc.
• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim GmbH
• Boston Scientific Corp.
• F. Hoffmann-La Roche, Ltd.
• GlaxoSmithKline Plc
• Medtronic PLC
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc.
• Siemens AG
• Takeda Pharmaceutical Co., Ltd.
• Terumo Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-silent-heart-attack-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mansi Jain
Phone 07803040404
Business Address Orion Market Research Pvt Ltd
305-308, Commerce House,
Country India
Categories Business , Health , Medical
Tags market analysis , market forecast , market research , medical devices
Last Updated August 12, 2020